Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.72%2.81T | -4.29%11.47T | -0.98%2.74T | 7.57%11.98T | 30.17%3.55T | -4.96%2.81T | 4.51%2.86T | 1.64%2.76T | -1.12%11.14T | -0.91%2.73T |
| Non interest income | 2.72%2.81T | -4.29%11.47T | -0.98%2.74T | 7.57%11.98T | 30.17%3.55T | -4.96%2.81T | 4.51%2.86T | 1.64%2.76T | -1.12%11.14T | -0.91%2.73T |
| -Total premiums earned | -2.18%1.43T | -8.64%6.16T | -8.13%1.46T | 5.80%6.74T | 38.35%2.18T | -9.26%1.45T | -4.55%1.52T | -0.97%1.59T | -1.23%6.37T | -3.36%1.58T |
| -Fees and commissions | 11.51%1.34T | 0.76%5.08T | -1.64%1.2T | 9.01%5.04T | 17.95%1.32T | -2.96%1.29T | 10.11%1.21T | 13.36%1.22T | -0.91%4.62T | 2.76%1.12T |
| -Including:Fees and commission income | 11.51%1.34T | 0.76%5.08T | -1.64%1.2T | 9.01%5.04T | 17.95%1.32T | -2.96%1.29T | 10.11%1.21T | 13.36%1.22T | -0.91%4.62T | 2.76%1.12T |
| -Gain loss on sale of securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---85.06B | ---- | ---- |
| -Total other operating income | -44.55%39.66B | 15.53%230.8B | 110.53%71.53B | 40.38%199.77B | 53.85%48.77B | 95.76%81.69B | -2.94%35.34B | 4.63%33.98B | -2.78%142.31B | -0.17%31.7B |
| Credit losses provision | ||||||||||
| Operating expense | 1.62%2.6T | -5.70%10.71T | -4.65%2.56T | 8.54%11.35T | 30.52%3.41T | -4.09%2.63T | 2.40%2.62T | 5.79%2.69T | 0.44%10.46T | 1.67%2.61T |
| Staff costs | 2.35%623.19B | 0.89%2.44T | 2.11%608.87B | -0.73%2.42T | -2.78%610.77B | 0.23%611.94B | -0.11%597.43B | -0.19%596.3B | 0.19%2.43T | 4.96%628.26B |
| Selling and administrative expenses | 1.75%1.86T | -5.38%7.83T | -5.23%1.83T | 6.29%8.28T | 35.81%2.59T | -7.47%1.9T | -4.02%1.86T | 1.95%1.93T | 5.25%7.79T | 1.87%1.91T |
| -General and administrative expense | 1.75%1.86T | -5.38%7.83T | -5.23%1.83T | 6.29%8.28T | 35.81%2.59T | -7.47%1.9T | -4.02%1.86T | 1.95%1.93T | 5.25%7.79T | 1.87%1.91T |
| Depreciation and amortization | 4.04%66.74B | 6.08%257.45B | 8.69%64.16B | 7.20%242.69B | 13.54%63.76B | 6.87%60.96B | 4.89%58.95B | 3.57%59.03B | -11.35%226.38B | -6.29%56.16B |
| -Depreciation | 4.04%66.74B | 6.08%257.45B | 8.69%64.16B | 7.20%242.69B | 13.54%63.76B | 6.87%60.96B | 4.89%58.95B | 3.57%59.03B | -11.35%226.38B | -6.29%56.16B |
| Other operating expenses | -11.92%53.93B | -56.82%180.6B | -40.52%61.23B | 3,161.88%418.24B | 660.95%142.32B | 115.49%65.99B | 455.14%106.99B | 1,713.51%102.94B | -96.12%12.82B | -49.09%18.7B |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -380.58%-2.33B | 211.78%1.4B | -74.30%829M | -97.37%450M | -239.51%-3.77B | -101.83%-154M | 187.38%1.15B | -56.07%3.23B | 284.74%17.13B | 134.09%2.7B |
| Less:Restructuring and mergern&acquisition | ---- | -128.91%-481M | ---- | -5.94%1.66B | -48.22%916M | --273M | ---- | ---- | --1.77B | --1.77B |
| Less:Other special charges | 136.70%600M | 40.11%-2.97B | 49.32%-1.64B | 77.62%-4.95B | 122.46%1.29B | 91.20%-856M | -396.16%-2.16B | 56.25%-3.23B | -1,002.99%-22.13B | -335.46%-5.76B |
| Less:Write off | 114.14%1.73B | -27.99%2.04B | --806M | -12.00%2.84B | 21.56%1.56B | -44.38%737M | -8.03%538M | --0 | -71.42%3.22B | -76.57%1.29B |
| Income before tax | 17.01%203.34B | 21.28%762.88B | 122.24%173.78B | -9.54%629.03B | 16.23%137.03B | -19.31%179.72B | 37.80%234.09B | -57.71%78.2B | -17.34%695.37B | -32.74%117.89B |
| Income tax | 18.49%56.81B | -9.97%163.47B | 9.54%47.94B | 3.93%181.57B | -1.03%43.3B | 55.17%39.52B | -0.15%54.98B | -13.19%43.77B | -21.58%174.71B | -13.80%43.76B |
| Net income | 16.44%146.53B | 33.96%599.41B | 265.51%125.84B | -14.06%447.46B | 26.43%93.73B | -28.92%140.2B | 56.00%179.11B | -74.40%34.43B | -15.82%520.67B | -40.46%74.14B |
| Net income continuous operations | 16.44%146.53B | 33.96%599.41B | 265.52%125.84B | -14.06%447.46B | 26.43%93.73B | -28.92%140.2B | 56.00%179.11B | -74.40%34.43B | -15.82%520.67B | -40.46%74.14B |
| Noncontrolling interests | 54.17%78.83B | 28.01%228.84B | 19.01%51.13B | 99.48%178.77B | 141.93%47.02B | 43.09%38.46B | 83.61%50.33B | 170.30%42.96B | -23.29%89.62B | -26.07%19.44B |
| Net income attributable to the company | -9.38%67.7B | 37.92%370.56B | 975.31%74.71B | -37.67%268.69B | -14.61%46.71B | -40.28%101.74B | 47.34%128.77B | -107.20%-8.54B | -14.08%431.05B | -44.32%54.7B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -9.38%67.7B | 37.92%370.56B | 975.31%74.71B | -37.67%268.69B | -14.61%46.71B | -40.28%101.74B | 47.34%128.77B | -107.20%-8.54B | -14.08%431.05B | -44.32%54.7B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -2.48%22.78 | 48.64%119.3 | 1,045.75%23.36 | -33.57%80.26 | -8.85%14.73 | -36.12%30.56 | 53.76%37.44 | -107.61%-2.47 | -8.42%120.82 | -39.72%16.16 |
| Diluted earnings per share | -2.48%22.78 | 48.64%119.3 | 1,045.75%23.36 | -33.57%80.26 | -7.83%14.5725 | -36.12%30.56 | 53.76%37.44 | -107.61%-2.47 | -8.42%120.82 | -41.03%15.8098 |
| Dividend per share | 0 | 0.00%50 | 0 | 0.00%50 | -50.00%25 | 0 | 25 | 0 | 0.00%50 | 0.00%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |